SK282523B6 - Použitie bakteriocínu obsahujúceho lantionín na výrobu liečiva a farmaceutický prípravok na vnútornú aplikáciu - Google Patents

Použitie bakteriocínu obsahujúceho lantionín na výrobu liečiva a farmaceutický prípravok na vnútornú aplikáciu Download PDF

Info

Publication number
SK282523B6
SK282523B6 SK837-94A SK83794A SK282523B6 SK 282523 B6 SK282523 B6 SK 282523B6 SK 83794 A SK83794 A SK 83794A SK 282523 B6 SK282523 B6 SK 282523B6
Authority
SK
Slovakia
Prior art keywords
nisin
citrate
chelating agent
bacteriocin
edta
Prior art date
Application number
SK837-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK83794A3 (en
Inventor
Peter Blackburn
Steven J. Projan
Edward B. Goldberg
Original Assignee
Applied Microbiology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Microbiology, Inc. filed Critical Applied Microbiology, Inc.
Publication of SK83794A3 publication Critical patent/SK83794A3/sk
Publication of SK282523B6 publication Critical patent/SK282523B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK837-94A 1992-01-17 1993-01-15 Použitie bakteriocínu obsahujúceho lantionín na výrobu liečiva a farmaceutický prípravok na vnútornú aplikáciu SK282523B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82243392A 1992-01-17 1992-01-17
US86613592A 1992-04-09 1992-04-09
PCT/US1993/000377 WO1993013793A1 (fr) 1992-01-17 1993-01-15 Compositions pharmaceutiques a base de bacteriocine

Publications (2)

Publication Number Publication Date
SK83794A3 SK83794A3 (en) 1995-06-07
SK282523B6 true SK282523B6 (sk) 2002-10-08

Family

ID=27124640

Family Applications (1)

Application Number Title Priority Date Filing Date
SK837-94A SK282523B6 (sk) 1992-01-17 1993-01-15 Použitie bakteriocínu obsahujúceho lantionín na výrobu liečiva a farmaceutický prípravok na vnútornú aplikáciu

Country Status (21)

Country Link
EP (1) EP0623024B1 (fr)
JP (1) JP3719520B2 (fr)
KR (1) KR100282166B1 (fr)
AT (1) ATE152353T1 (fr)
AU (1) AU672384B2 (fr)
BR (1) BR9305754A (fr)
CA (1) CA2127987C (fr)
CZ (1) CZ282676B6 (fr)
DE (1) DE69310346T2 (fr)
DK (1) DK0623024T3 (fr)
ES (1) ES2102010T3 (fr)
FI (1) FI943261A (fr)
GR (1) GR3024049T3 (fr)
HU (1) HU219234B (fr)
IL (1) IL104364A (fr)
MX (1) MX9300207A (fr)
NO (1) NO314221B1 (fr)
NZ (2) NZ299034A (fr)
RU (1) RU2104710C1 (fr)
SK (1) SK282523B6 (fr)
WO (1) WO1993013793A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307352A1 (de) * 1992-10-29 1994-05-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes
JPH08504401A (ja) * 1992-10-29 1996-05-14 デネッケ，ライナー 消化管疾患の治療および特に予防用製剤
AU689494B2 (en) * 1993-08-20 1998-04-02 Boehringer Ingelheim Vetmedica Gmbh Method for the prevention and treatment of bovine mastitis
US5958873A (en) * 1997-06-09 1999-09-28 University Of Cincinnati Oral formulation for treatment of bacteria-induced diseases of the colon
AU2002300676B2 (en) * 1997-06-09 2006-02-09 Ambi Inc. A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
CA2379040C (fr) * 1999-03-05 2010-01-26 Shanbrom Technologies, Llc Concentres solubles de couleurs naturelles et nutraceutiques antimicrobiens a base de plantes
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
KR100375342B1 (ko) * 2000-02-08 2003-03-08 주식회사 풀 무 원 위장 질환 개선을 위한 천연 항균물질 조성물
DE10110431A1 (de) * 2001-03-05 2002-09-19 Nutrinova Gmbh Bacteriocinhaltiges Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht
DE10326346A1 (de) * 2003-06-12 2004-12-30 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verwendung von Sorbinsäure zur Vermeidung von bakteriellen Infektionen und als Leistungsförderer bei Tieren
EP2206506A1 (fr) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Formulations probiotiques
JP2010270015A (ja) * 2009-05-19 2010-12-02 Adeka Clean Aid Co Ltd 乳房炎予防剤
US20110053832A1 (en) * 2009-09-03 2011-03-03 Kraft Foods Global Brands Llc Natural antimicrobial composition
JP5909821B2 (ja) * 2012-02-22 2016-04-27 株式会社Adeka ナイシン含有抗菌性組成物
CN110898211A (zh) * 2019-12-02 2020-03-24 福建省闽东水产研究所 一种体外抑制大黄鱼内脏白点致病菌的抑菌组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631803B2 (en) * 1988-06-22 1992-12-10 Applied Microbiology, Inc Nisin compositions for use as enhanced, broad range bactericides
NZ244737A (en) * 1989-02-21 1993-09-27 Viskase Corp Food packaging polymeric film containing antibiotic material; method of treating foodstuff and food casing therefor

Also Published As

Publication number Publication date
BR9305754A (pt) 1997-10-21
CZ166194A3 (en) 1995-02-15
AU672384B2 (en) 1996-10-03
HUT70839A (en) 1995-11-28
CZ282676B6 (cs) 1997-08-13
EP0623024B1 (fr) 1997-05-02
GR3024049T3 (en) 1997-10-31
CA2127987C (fr) 2002-08-13
SK83794A3 (en) 1995-06-07
RU94037764A (ru) 1996-07-27
HU9402110D0 (en) 1994-09-28
NO942644L (no) 1994-09-07
ATE152353T1 (de) 1997-05-15
DE69310346D1 (de) 1997-06-05
DK0623024T3 (da) 1997-12-01
FI943261A (fi) 1994-09-07
WO1993013793A1 (fr) 1993-07-22
KR100282166B1 (ko) 2001-02-15
RU2104710C1 (ru) 1998-02-20
NZ299034A (en) 2000-08-25
DE69310346T2 (de) 1997-08-21
HU219234B (en) 2001-03-28
EP0623024A1 (fr) 1994-11-09
IL104364A0 (en) 1993-05-13
NO314221B1 (no) 2003-02-17
JP3719520B2 (ja) 2005-11-24
MX9300207A (es) 1994-07-29
ES2102010T3 (es) 1997-07-16
JPH07508499A (ja) 1995-09-21
FI943261A0 (fi) 1994-07-08
NZ249007A (en) 1996-11-26
AU3475093A (en) 1993-08-03
NO942644D0 (no) 1994-07-14
CA2127987A1 (fr) 1993-07-22
IL104364A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
US5304540A (en) Pharmaceutical bacteriocin compositions and methods for using the same
US5334582A (en) Pharmaceutical bacteriocin compositions and methods for using the same
SK282523B6 (sk) Použitie bakteriocínu obsahujúceho lantionín na výrobu liečiva a farmaceutický prípravok na vnútornú aplikáciu
JP4855573B2 (ja) 抗ウイルス製剤の使用
USRE37793E1 (en) Method and composition for inhibiting bacteria
CA2241464C (fr) Combinaison de nisine et de monolaurate de glycerol agissante contre helicobacter
Stables et al. Gastric anti‐secretory, mucosal protective, anti‐pepsin and anti‐Helicobacter properties of ranitidine bismuth citrate
CZ286286B6 (cs) Aplikační forma, sterilizační prostředek, doplňkové krmivo a způsob sterilizace
Koga et al. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori
Brunner et al. Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice
WO1997025032A2 (fr) Compositions a base de monoglycerides et leur utilisation contre helicobacter
Goodwin et al. Differences between in vitro and in vivo sensitivity of Campylobacter pylori to antibacterials
KR20010077797A (ko) 위장 질환 개선을 위한 천연 항균물질 조성물
EP0666759A1 (fr) Preparation permettant d'assurer la therapie et notamment la prophylaxie de maladies du tractus digestif
WO1999027931A1 (fr) Utilisation de bicozamycine pour produire un medicament servant a traiter des infections a e. coli enterohemorragique
JPH0812576A (ja) 抗ヘリコバクター・ピロリ剤
WO2001074370A1 (fr) Utilisation de feracryl pour le traitement des ulceres pectiques/du duodenum et/ou du cholera
WO2008058993A2 (fr) Nouvelle utilisation de composés chimiques actifs connus en pharmacologie